Panacea Acquisition Corp. II Class A Ordinary Shares
PANA
PANA was delisted on the 18th of April, 2023.
0 hedge funds and large institutions have $0 invested in Panacea Acquisition Corp. II Class A Ordinary Shares in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 54 closing their positions.
100% less funds holding
Funds holding: 54 → 0 (-54)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $170M → $0 (-$170M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 54
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
-$17.1M |
| 2 |
6CM
683 Capital Management
New York
|
-$15.1M |
| 3 |
MC
Maverick Capital
Dallas,
Texas
|
-$14.2M |
| 4 |
FTCM
First Trust Capital Management
Chicago,
Illinois
|
-$11.3M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$9.71M |
PANA Hedge Fund Activity: Q2 2023 in Review
0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) for Q2 2023, worth a combined $0 — down 100% from $170M a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of PANA and 0 opened new positions — a net loss of 54 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Aristeia Capital, exiting entirely with an estimated $17.1M sold.
- 0 institutional investors held Panacea Acquisition Corp. II Class A Ordinary Shares (PANA) as of Q2 2023, down from 54 in Q1 2023.
- Funds reported $0 of Panacea Acquisition Corp. II Class A Ordinary Shares stock for Q2 2023, down 100% quarter-over-quarter.
- 0 funds opened new Panacea Acquisition Corp. II Class A Ordinary Shares positions in Q2 2023 and 54 closed out, a net change of -54 holders.
- The largest Panacea Acquisition Corp. II Class A Ordinary Shares seller in Q2 2023 was Aristeia Capital, an estimated $17.1M sold.
Based on aggregated 13F filings for Q2 2023.